The heat-stable antigen (HSA) is a glycosyl-phosphatidylinositol-anchored cell surface protein (1, 5, 34, 39) . Recent studies from several groups revealed that HSA plays a major role in regulating interaction between T and B lymphocytes (12, 19, 28, 29) , T-cell clonal expansion (10, 18, 29) , and induction of immunological memory (30, 41) . The expression of HSA is largely restricted to cells of hematopoietic (1, 5, 34, 36) and neuronal (19, 36) origins. Among the hematopoietic cells, HSA is expressed on a variety of cell types, including erythrocytes (39) , thymocytes (5), B cells (5, 19, 29, 36) , macrophages (8) , and Langerhans cells (10) .
The expression of HSA is strictly regulated during the development of T and B lymphocytes (7, 27) . In the T-cell lineage, HSA is expressed at high levels on a subset of CD4 Ϫ
CD8
Ϫ thymocytes and all CD4 ϩ CD8 ϩ immature thymocytes. The levels of HSA on CD4 ϩ and CD8 ϩ single-positive thymocytes are inversely correlated with their maturity (7) . While HSA is not expressed on the majority of peripheral T cells, it is rapidly induced during T-cell activation (15) . In the B-cell lineage, HSA is expressed at high levels on pro-and pre-B cells and at intermediate levels on peripheral B cells (27, 42) , but it is absent on terminally differentiated plasma cells (27) . The strict control of HSA expression suggests that it may also play an important role in lymphocyte development and differentiation. This is supported by findings that constitutive overexpression of HSA in lymphoid tissues leads to defective development of T and B cells (13, 14) . However, the molecular basis for the regulated HSA expression has not been elucidated, although it is known that the amounts of cell surface HSA in different tissues and cell lines correlate with the steady-state levels of cellular HSA mRNA (17, (20) (21) (22) 44) . mRNA levels are determined by the rate of de novo RNA synthesis as well as the efficiency of posttranscriptional RNA processing, such as polyadenylation, splicing, transport, and degradation of mRNA. Accumulating data have suggested a major role of the 3Ј untranslated region (3ЈUTR) in determining the stability of mRNA (3, 9, 16, 18, 26, 40) . Many cytokine and oncogene mRNAs have long 3ЈUTRs and are short-lived (2, 38) , primarily due to active degradation by mechanisms involving AU-rich cis elements, such as multiple copies of AUUUA. Since HSA mRNA has a very short (0. 23-kb) open reading frame (ORF) and a relatively long (1.5-kb) 3ЈUTR, we investigated whether HSA expression is controlled by its 3ЈUTR. Here we report that the interplay of cis elements in the 3ЈUTR of HSA mRNA determines cell surface HSA expression by modulating its mRNA degradation.
MATERIALS AND METHODS
Plasmid construction. All cDNA constructs described here were cloned into the mammalian expression vector pCDM8 (Invitrogen, San Diego, Calif.). HSAFull contains a 1.8-kb fragment of full-length HSA cDNA originally cloned from lipopolysaccharide-stimulated murine spleen cells (28) . HSA-DelA has a deletion of a 1,360-bp fragment within the 3ЈUTR (nucleotides [nt] 440 to 1800). It was generated by digesting HSA-Full with EcoRI and NotI and religating the remaining plasmid fragment with a 38-bp EcoRI-NotI linker derived from pBluescript (Stratagene, San Diego, Calif.). HSA-DelB has a deletion of an 849-bp fragment within the 3ЈUTR between nt 440 and 1289. It was generated by digesting HSA-Full with EcoRI, removing an 849-bp EcoRI fragment, and religating the linear plasmid. HSA-pA-M is a mutant of HSA-Full, with the polyadenylation signal (AATAAA) at positions 993 to 998 changed to AgcAAA by PCR-based site-directed mutagenesis.
HSA-N1, -N2, -N3, -N4, -N5, -N6, and N7 consist of HSA nt 1 to 440 and a portion of nt 1289 to 1800. They were generated by inserting PCR fragments corresponding to different regions of the distal 3ЈUTR (nt 1289 to 1800) into HSA-DelA at EcoRI and NotI sites.
B7-2 cDNA in the pCDM8 vector has been reported before (43) . It contains the entire 969-bp coding region of a costimulatory molecule, B7-2. B7-2-NE is composed of the B7-2 coding region and part of 3ЈUTR of HSA mRNA. It was generated by ligating a 0.51-kb distal 3ЈUTR fragment (nt 1289 to 1800) downstream of the B7-2 ORF.
Nine constructs, H3, AccS, AccL, and P1 to 6, were produced to identify the positive cis elements. These constructs all contain fragments spanning nt 1 to 440 and 1289 to 1800 of HSA-Full. Portions of the fragment from nt 440 to 1289 were inserted between these two fragments. Inserts of various lengths were produced by either restriction enzyme digestion or PCR.
The sequences and orientations of all these cDNA constructs were confirmed by direct DNA sequencing. The primer sequences used for the study are available on request.
Cell culture and DNA transfection. COS cells were cultured in Dulbecco modified Eagle medium containing 5% fetal calf serum at 37°C and were used for transient transfection by the DEAE-dextran method. Briefly, 10 6 COS cells were seeded in each 100-mm-diameter tissue plate. On the next day, COS cells were incubated with 5 ml of transfection medium (500 g of DEAE-dextran per ml, 0.1 M chlorioquine, and 15 g of plasmid DNA) for 2 to 3 h at 37°C. The cells were then shocked with 5 ml of 10% dimethyl sulfoxide in phosphatebuffered saline (PBS) for 2 min, washed twice with serum-free Dulbecco modified Eagle medium, and then cultured for 2 to 3 days. In some experiments, transfectants were split at 24 h after transfection and treated with either actinomycin D (ActD) (5 g/ml) (Sigma, St. Louis, Mo.) or cycloheximide (CHX) (50 g/ml) (Sigma) at 40 h after transfection.
Cell surface HSA expression determined by flow cytometry. Three days after transfection, COS cells were detached from plates by incubation with 5 mM EDTA-PBS solution. After being washed with PBS once, COS cells (5 ϫ 10 5 /sample) were incubated with 100 l of anti-HSA monoclonal antibody (MAb) M1/69 hybridoma supernatants (39) or the unrelated MAb GK1.5 as a control on ice for 30 min. After three washes with staining buffer (PBS containing 1% fetal calf serum), cells were incubated with 100 l of a 1:100 dilution of fluorescein isothiocyanate-conjugated mouse anti-rat immunoglobulin G (Caltag, Mountain View, Calif.) for another 30 min. After unbound conjugates were removed, cells were fixed in 200 l of 1% paraformaldehyde-PBS solution and cell surface fluorescence was measured with a FACScan (Becton Dickinson, Mountain View, Calif.).
Northern blot analysis. Cytoplasmic and nuclear RNAs were isolated as described previously (37) . Total cellular RNA was isolated by the guanidium isothiocyanate extraction method (6) . Poly(A)
ϩ RNA was isolated with Oligotex mRNA kits (Qiagen, Santa Clarita, Calif.) according to the manufacturer's instructions. RNA (15 g/sample) was separated on a 1.2% formaldehyde agarose gel by electrophoresis and transferred to nitrocellulose membranes. The membranes were prehybridized at 42°C for 4 to 10 h by incubation with prehybridization solution (50% formide, 5ϫ SSPE [1ϫ SSPE is 0.18 M sodium chloride, 0.01 M sodium phosphate, 1 mM EDTA; pH 7.7], 1 mM EDTA, 0.1% sodium dodecyl sulfate [SDS] , and 100 g of denatured salmon sperm DNA per ml).
32 P-labeled DNA probes were then added and incubated with the membranes at 42°C overnight. At the end of hybridization, membranes were washed once with 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS at room temperature, twice with 2ϫ SSC-0.1% SDS at 42°C, and once with 0.2ϫ SSC-0.1% SDS at 60°C, with exchanges of the washing solution at intervals of 20 min. After the final wash, membranes were rinsed with 2ϫ SSC, and then exposed to X-OMAT imaging films (Kodak, Rochester, N.Y.). In some experiments, the densities of the bands were quantified with a densitometer. The predicted sizes of mRNA were calculated based on the predicted transcription initiation site and the cleavage site for polyadenylation: predicted size ϭ size of 5Ј vector sequence (0.1 kb) ϩ size of cDNA insert ϩ size of 3Ј vector sequence (0.67 kb).
Nuclear run-on assay. The nuclear run-on assay was performed as described previously (11) . The run-on products (10 7 cpm/sample) were hybridized to nitrocellulose membranes immobilized with DNA fragments corresponding to different portions of HSA cDNA or control DNA.
HSA-transgenic mice. The production of HSA-transgenic mice has been reported previously (44) . Briefly, HSA cDNA was inserted into the p1017 cassette transgenic vector (kindly provided by Roger Perlmutter, University of Washington, Seattle. The expression of the HSA cDNA is controlled by a proximal lck promoter, and the 3Ј processing is aided by a portion of human growth hormone gene. Transgenic mice derived from founder A, which has approximately 40 copies of the HSA transgene, were used for the study. Total RNAs, isolated from the spleens and thymuses of HSA transgenic mice, their littermate controls, HSA-deficient mice (33) , or C57BL/6j mice, were analyzed by Northern blotting.
RESULTS
Positive and negative regulation of steady-state levels of HSA mRNA by its 3UTR. To investigate whether the 3ЈUTR of HSA mRNA contains cis elements that control HSA expression, we generated two deletion mutants of HSA cDNA: HSADelA and HSA-DelB (Fig. 1a) . HSA-DelA has a deletion of a 1,360-bp fragment spanning nt 440 to 1800, while HSA-DelB has a deletion of an 849-bp fragment spanning nt 440 to 1289. These two deletion mutants and the full-length HSA cDNA were cloned in the expression vector pCDM8. Individual plasmids containing each of these HSA cDNAs were cotransfected with the pCDM8 vector into COS cells by the DEAE-dextran method.
We first examined the HSA protein expression by flow cytometry. As shown in Fig. 1b (Fig. 1c, upper  panel) . Significant amounts of HSA mRNA were detected in COS cells transfected with HSA-Full but not in those transfected with vector alone. The highest levels of HSA mRNA were observed in HSA-DelA transfectants, while minimal amounts of HSA mRNA were detected in HSA-DelB transfectants. The differences are not due to transfection efficiency, because comparable levels of the cotransfected vector RNA were detected in all four transfectants (Fig. 1c, middle panel) . In addition, the observed differences cannot be accounted for by variations in RNA loading (Fig. 1c, lower panel) . These results demonstrate that the 3ЈUTR determines the levels of steady-state HSA mRNA, which in turn determine the amounts of HSA protein expressed. Since deletion of a middle portion in the 3ЈUTR (nt 440 to 1289) leads to a reduction in HSA mRNA and protein expression, positive cis elements may exist in this region. Moreover, a further deletion of the distal 3ЈUTR (nt 1289 to 1800) results in the highest levels of HSA expression; it is likely that negative cis-acting elements are present in the distal region.
The length of HSA mRNA detected does not correspond to that of HSA cDNA inserts, as three inserts of different lengths, ranging from 0.44 to 1.8 kb, give mRNAs of similar sizes, 1.1 to 1.2 kb. This apparent discrepancy can be explained by utilization of different polyadenylation sites in different constructs. The HSA-Full insert has a functional polyadenylation signal (AATAAA) at positions 993 to 998, utilization of which would lead to an mRNA of about 1.1 kb, as is the majority of HSA mRNA detected. In addition, a less abundant 2.6-kb HSA mRNA was detected, which is expected if the polyadenylation site on the vector is utilized. Since the HSA-DelA insert has no polyadenylation signal, it has to utilize the polyadenylation signal from the vector, which is 0.67 kb downstream. The mature HSA-DelA mRNA should be 1.2 kb. In order to verify this explanation, we mutated the polyadenylation signal in the 3ЈUTR of HSA-Full. As shown in Fig. 2a , mutation of the polyadenylation signal AATAAA to AgcAAA abrogated the accumulation of the 1.1-kb form of HSA mRNA and led to a preferential accumulation of the 2.6-kb HSA mRNA. These results demonstrate that the 1.1-kb HSA mRNA is due to utilization of the polyadenylation site in inserted HSA cDNA. In addition, since the 2.6-kb mRNA contains both positive and negative elements, it is likely that the function of the positive element dominates over that of the negative element. Moreover, the majority of HSA mRNA in the HSA-Full-transfected cells contained the putative positive but not the negative elements, yet its level was not higher than that in the COS cells transfected with HSA-DelA, which lacks both positive and negative cis elements. It is therefore likely that the sole function of the positive cis element is to neutralize the activity of the negative cis element. The HSA-pA-M and HSA-Full mRNAs were translated with comparable efficiencies, as similar levels of cell surface HSA were detected (Fig. 2b) .
The 3UTR of HSA mRNA does not affect the transcription rate. To determine the transcription rates of HSA-Full and HSA-DelB inserts in COS transfectants, we performed nuclear run-on assays with immobilized DNA fragments from different regions of HSA cDNA or control actin cDNA, to quantify nascent nuclear RNA. As shown in Fig. 3a , nascent RNA in HSA-Full-transfected COS cells hybridized to cDNA fragments corresponding to nt 38 to 440 and 440 to 1289, while those in HSA-DelB transfectants hybridized to HSA cDNA nt 38 to 440 but not HSA nt 440 to 1289, which is absent in HSA-DelB. Further experiments using other regions of HSA cDNA as probes (Fig. 3b) revealed that the transcripts from HSA-DelB transfectants contain all the HSA sequences in the construct. After being normalized with control actin, the amounts of run-on products from both HSA-Full and HSADelB were almost identical. Thus, HSA-Full and HSA-DelB transfectants transcribed the HSA gene at comparable rates, and the lack of functional HSA mRNA in the HSA-DelB transfectants must be due to posttranscriptional mechanisms.
Stability of HSA mRNAs transcribed from HSA-full and HSA-DelB. As a preliminary approach to determining the mechanisms responsible for posttranscriptional regulation of HSA mRNA, we treated HSA cDNA transfectants with either ActD, which inhibits transcription, or CHX, which blocks both translating and RNA degradation, and then determined the levels of steady-state HSA mRNA by Northern blotting ( Evidence for an endonucleic cleavage of the HSA-DelB RNA. Since the HSA-DelB insert does not have a polyadenylation signal sequence with a correct downstream cleavage sequence, the mRNA transcript must use the signal and processing sequences from the vector for efficient polyadenylation. The mRNA transcript is predicted to be of 1.7 kb rather than the 0.9 and 1.1 kb protected by the CHX. To confirm that the 1.7-kb HSA mRNA is transcribed from the HSA-DelB construct, we prepared nuclear and cytoplasmic RNAs from the HSA-Full-and HSA-DelB-transfected COS cells and analyzed the size of the HSA RNA. As shown in Fig. 6a , nuclear RNA derived from HSA-Full was comprised of 1.2-and 2.6-kb species, corresponding to alternative polyadenylation. Both species were present in the cytoplasm, as predicted. HSA-DelB nuclear RNA was composed of 1.7-and Ͼ3-kb species. The 1.7-kb RNA is likely to be the full-length transcript of HSADelB that utilized the vector polyadenylation signal. The nature of the Ͼ3.0-kb species is not understood at present, but such larger-than-expected RNA has been reported to be associated with production of unstable mRNA (35) . The 0.9-and 1.1-kb RNAs were not found in the nuclear RNA. Interestingly, the cytoplasmic HSA-DelB mRNA was selectively devoid of the 1.7-kb band while enriched for the 0.9-and 1.1-kb bands. These results strongly suggest that the 1.7-kb RNA is the precursor for the 0.9-and 1.1-kb RNAs in the cytoplasm.
To determine if the HSA-DelB RNA observed in the cytoplasm is polyadenylated, we divided the cytoplasmic RNA into two aliquots; one was left untreated, and the other was incubated with oligo(dT)-coated resin to obtain poly(A) ϩ RNA. As shown in Fig. 6b , all major species of HSA-Full RNA were recovered with high efficiency, while the overwhelming majority of the HSA-DelB RNA did not bind to the oligo(dT) resin. It is unclear at this stage whether the minute amount of the HSA-DelB RNA observed in the poly(A) ϩ fraction is due to incomplete removal of the poly(A) Ϫ fraction in the experiment or due to existence of a small amount of polyadenylated HSA DelB RNA. These results demonstrate that most, if not all, of the HSA-DelB RNA lacks the poly(A) tail, which explains the short half-lives of these fragments. Moreover, while the ORFcontaining HSA-DelB RNA was rapidly degraded, we have detected, in separate experiments, substantial amounts of HSA-DelB RNA in the cytoplasm by using the HSA (nt 1289 to 1625) and downstream vector sequence as probes (Fig. 6c) . Taken together, the results presented in this section suggest that newly transcribed 1.7-kb RNA may be subject to rapid endonucleic cleavage, perhaps at multiple sites, to generate a spectrum of 0.9-to 1.1-kb products; the ORF-containing ones are devoid of poly(A) and are rapidly degraded, while the 3Ј fragments are polyadenylated and accumulate in a large quantity.
The distal 3UTR (nt 1289 to 1800) of HSA mRNA promotes degradation of heterologous mRNA. To determine whether the distal 3ЈUTR fragment alters the stability of heterologous mRNA, we linked this fragment to the 3Ј end of the B7-2 ORF to produce B7-2-NE. Both B7-2 and B7-2-NE were transfected into COS cells. After drug treatment, RNAs were isolated and the amounts of B7-2 mRNA were measured by Northern blotting. As shown in Fig. 7 , in the absence of any treatment, a strong 1.7-kb band was detected in B7-2 transfectants, while a weak 2.3-kb band, the predicted full-length B7-2-NE mRNA, was observed in the B7-2-NE transfectants. ActD decreased the levels of B7-2 and B7-2-NE mRNA, while CHX increased both levels. Both drugs were more effective for B7-2-NE mRNA than for B7-2 mRNA. Moreover, CHX-treated B7-2-NE transfectants had an additional 1.4-kb band, perhaps a truncated product of the 2.3-kb mRNA. These results indicate that the 3ЈUTR of HSA mRNA promotes degradation of B7-2 mRNA. It should be noted that the degradation of B7-2-NE mRNA is not as efficient as that of HSA-DelB mRNA. In particular, we have observed a significant protection of the intact B7-2-NE by CHX. Thus, the context of the ORF modulates the efficiency of NE-mediated RNA degradation.
Delineation of a negative cis-acting element in the distal 3UTR. To further define the cis elements responsible for the accelerated RNA degradation, we generated HSA-N1 to -N4, each with a different deletion within the distal 3ЈUTR (nt 1289 to 1800) (Fig. 8a) , and measured the RNA and protein expression of the mutants in COS transfectants (Fig. 8b and c) . It was anticipated that deletions of negative cis-acting elements would restore HSA expression. However, in three deletion mutants, HSA-N1, -N2, and -N4, HSA expression was not restored as judged by the amounts of HSA mRNA and protein.
In addition, much like the HSA-DelB mRNA, the majority of the HSA RNAs detected were either smaller or larger than predicted. However, one construct, HSA-N3, restored HSA expression to a level comparable to that in HSA-Full transfectants. The major mRNA species in N3 transfectants was 1.5 kb, the predicted size of mature N3 mRNA.
HSA-N3 has a 135-bp deletion from HSA-N4 in the region of nt 1465 to 1600, thus raising the possibility that this fragment may be largely responsible for the accelerated RNA degradation. Furthermore, since HSA-N2 and HSA-N4 share 30 bp, it Northern blot analysis for B7-2 mRNA in COS cells transfected with either B7-2 or B7-2-NE is shown. The B7-2 insert is comprised of a 1.0-kb B7-2 cDNA ORF, while B7-2-NE is a chimera cDNA consisting of the B7-2 ORF and part of the 3ЈUTR (nt 1289 to 1800) of HSA mRNA. The sizes of the predicted mature mRNAs are 1.8 kb for B7-2 and 2.3 kb for B7-2-NE. Aliquots of COS cells transfected with B7-2 cDNA or B7-2-NE were left untreated (Nil) or treated with ActD or CHX for 4 h. The total RNA was then isolated, and the amount of B7-2 mRNA was determined by Northern blotting with a 32 P-labeled B7-2 probe. The loading of RNA is shown in the bottom panels. Numbers above the bottom panels are the relative amounts of B7-2 mRNA after the drug treatment. The amounts in untreated cells are defined as 1.0. is tempting to suggest that this 30-bp fragment may be the negative cis element. We created HSA-N5, -N6, and -N7 to test these possibilities. As shown in Fig. 8c , deletion of nt 1465 to 1625, as in the N5 construct, restored HSA expression as judged by a selective increase of a 1.6-kb HSA mRNA and high levels of HSA protein. Thus, this region is necessary for efficient RNA degradation. Moreover, the lack of mature HSA mRNA in N6-transfected COS cells indicated that the fragment from nt 1465 to 1625 is sufficient to abolish accumulation of mature mRNA. Interestingly, significant amounts of two small HSA mRNAs were detected, which suggests that the fragment from nt 1465 to 1625 is only sufficient to convey partial degradation of HSA mRNA. The 30-bp fragment shared by HSA-N2 and -N4 did not promote RNA degradation and has no effect on protein expression, as in the case of the N7 construct. Taken together, the results presented in this section demonstrate that a 160-bp fragment in the distal 3ЈUTR is both necessary and sufficient to promote HSA mRNA degradation.
A 43-bp element inhibits degradation of HSA mRNA. In order to delineate the positive cis element that neutralizes the function of the negative cis element, we generated a large series of deletion mutants that contain the HSA sequence from nt 1 to 440 and nt 1290 to 1800 and overlapping fragments that cover all sequence between nt 440 and 1289 (Fig. 9a) . These constructs were transfected into COS cells, and the cell surface HSA expression was determined by flow cytometry with anti-HSA MAb M1/69. The data presented in Fig. 9a show relative HSA expression, with that of HSA-Full defined as 100. Insertion into HSA-DelB of most fragments that contain a 43-bp fragment, such as AccL, P4, P5, and P6, restored the cell surface HSA expression to levels comparable to that of HSAFull. These results indicate that extension of the 43-bp fragment in the 3Ј end does not increase the efficiency of the positive cis element. Further experiments revealed that removing the sequence adjacent to either end of the 43-bp fragment had no effect on the fragment (data not shown). These results demonstrate that most, if not all, of the positive activity within the nt 440 to 1289 region resides within a 43-bp fragment between nt 440 and 482. The sequence of the 43-bp fragment is shown at the bottom of Fig. 9a . Moreover, the H3 fragment was inserted opposite to its natural orientation, which results in reversion of the 43-bp fragment. Since this fragment did not restore HSA expression, it is likely that the function of the 43-bp fragment is orientation dependent.
We have analyzed the RNA accumulation in COS cells transfected with all mutants listed in Fig. 9a . Total RNA was isolated, and the HSA mRNA was determined by Northern   FIG. 9 . A 43-bp fragment is necessary and sufficient to neutralize the effect of the negative cis element residing within nt 1289 to 1800. (a) Diagram of the constructs and the relative amounts of cell surface HSA expression. All constructs contain the HSA nt 1 to 440 and 1289 to 1800 fragments. A portion of the putative positive regulatory region was inserted between the two fragments. Except for a reverse orientation of the H3 fragment, all fragments are inserted in their natural orientation. Cell surface HSA protein expression was determined by flow cytometry with anti-HSA MAb M1/69. The data presented are relative HSA expression based on the mean fluorescences of the samples, with standard deviations (SD), and are summaries of two or three independent measurements for each group. The expression of HSA-Full is defined as 100. The sequence of the minimal cis element is shown at the bottom. (b) Steady-state HSA mRNA levels in COS cells transfected with HSA-Full, DelB, AccS, P1, P2, P3, and AccL. Total RNA was used for the study. HSA(38-440) was used as the probe in the top panel. Bottom, the same blot was reprobed with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe to quantify the RNA loading. (c) As in panel b, except that HSA mRNAs in H3, P4, and P5 transfectants were determined. (d) A 43-bp oligonucleotide contains all necessary signal for neutralization of the negative cis element residing between nt 1289 and 1800. As in panels b and c, except a photograph of the gel is used to illustrate RNA loading (bottom).
blotting. The results for all of the mutants are presented in Fig.  9b to d. Insertion of AccL and P4 to -6 fragments, but not P1 to -3 fragments, restored the HSA mRNA levels to that of HSA-Full. Two major species of HSA mRNA, of 1.1 and 2.3 kb, were observed in AccL transfectants, most likely because AccL contains a polyadenylation signal. The sizes of P4 to -6 were as predicted. As shown in Fig. 9d , a difference of a 43-bp fragment between HSA-DelB and P6 has a major effect on the amount of HSA mRNA accumulated. These results clearly demonstrate that the 43-bp cis element promotes accumulation of HSA mRNA by neutralizing the negative cis element residing within the nt 1289 to 1800 region.
Preferential utilization of the second polyadenylation site in the endogenous HSA gene. We have shown that HSA mRNA that is accumulated in the HSA-Full-transfected COS cells preferentially utilizes the first polyadenylation site, which results in an absence of the negative cis element identified in this study. Since the HSA cDNA used in this study lacks the necessary downstream element for polyadenylation (25) , the preferential utilization of the first poly(A) signal is most likely due to inactivation of the second poly(A) site. In cell lines that express endogenous HSA, such as A20, M12, and CRCS, the majority of HSA mRNA was 1.9 kb, presumbly due to utilization of the second polyadenylation site (Fig. 10a) . A small fraction of HSA mRNA was 1.1 kb and thus utilized the first poly(A) signal. To directly compare the polyadenylation sites of the HSA cDNA and endogenous HSA gene, we compared the sizes of transgenic HSA mRNA with those of the endogenous HSA gene, we compared the sizes of transgenic HSA mRNA with those of the endogenous HSA gene. The vector used for the HSA-transgenic mice consists of a proximal lck promoter, full-length HSA cDNA, and a portion of the human growth hormone gene for RNA processing. The mice used for the current study were derived from founder A, which had approximately 40 copies of the transgene (data not shown). Northern blot analysis revealed that the HSA transgene is expressed at a higher level in the thymus than in the spleen (Fig. 10b) , which is consistent with the property of the vector. In the spleen, the transgene was expressed at a level comparable to that of the endogenous HSA gene. Most importantly, while the major species of the HSA RNA in littermate control mice was 1.9 kb, the predominant species of the HSA derived from the transgene was 1.1 kb. Moreover, the majority of the endogenous HSA mRNA contain both positive and negative cis elements identified in the study. The fact that the mRNA derived from HSA cDNA in the transgenic mice cannot efficiently utilize the second polyadenylation signal at its distal 3Ј end can be due to a lack of downstream sequence. Alternatively, it is possible that there is a limiting factor that inhibits the utilization of the first polyadenylation signal in normal mice but that this putative inhibitor is titrated out due to increased HSA expression in the transgenic mice.
DISCUSSION
HSA cDNA consists of a short ORF (231 bp) and a long 3ЈUTR (1,497 bp). Partial deletion of the 3ЈUTR abolishes the mRNA accumulation in the cytoplasm and, consequently, the cell surface expression of HSA. Since further truncation of the 3ЈUTR restores HSA expression, we conclude that the region between nt 1289 and 1800 contains a negative cis element(s) that down-regulates the expression of HSA. The addition of a fragment from nt 440 to 1289 neutralizes the negative effect of the fragment from nt 1289 to 1800. These results indicate that the 3ЈUTR of HSA mRNA plays an important role in controlling HSA expression.
Several lines of evidence support the notion that these cis elements regulate the stability of HSA mRNA. First, the transcription rate of the HSA mRNA is not altered by changing the composition of the 3ЈUTR. Second, the accumulation of cytoplasmic HSA mRNA is significantly enhanced by treatment with CHX, a protein synthesis inhibitor that has been shown to increase RNA stability for a large number of genes studied. Most importantly, the half-life of RNA derived from HSADelB is at least eightfold shorter than that of RNA derived from the full-length HSA cDNA.
Similar to most unstable RNAs, the fragment from nt 1289 to 1800 of HSA mRNA contains multiple stretches of AU-rich elements, including one AUUUA motif. However, deletion analysis reveals that this AUUUA motif is neither necessary nor sufficient for promoting HSA mRNA degradation. Deletions including this motif (as in the cases of HSA-N1 and HSA-N2) do not restore expression of HSA. In contrast, HSA-N3, which retains this motif, still expresses HSA at a high level. Such a lack of effect of the AUUUA element on mRNA accumulation can be due to the fact that it is not multimerized, as in the case of proto-oncogenes and cytokines (2, 38) . Alternatively, as suggested by recent studies, a longer motif, UUA UUUAUU, may be needed for RNA destabilization (24, 45) .
Our deletion analyses have revealed that a 160-bp fragment is both necessary and sufficient for rapid degradation of HSA mRNA. Deletion of the element in HSA-N5 leads to accumulation of substantial amounts of HSA mRNA and cell surface HSA, while addition of this fragment to HSA-DelA abrogated accumulation of mature HSA mRNA and cell surface HSA protein. Interestingly, this 160-bp fragment does not appear to contain all the activities of the fragment from nt 1289 to 1800 in the HSA-DelB construct. Thus, while HSA-N6 transfectants lack mature HSA mRNA, they do accumulate short HSA mRNA. It is therefore likely that other sequence within the nt 1289 to 1800 region may be responsible for rapid degradation of the apparently truncated HSA RNA. With a few notable exceptions (4, 23, 31, 32) , RNA degradation in mammalian cells proceeds rapidly after initiation, and the intermediate degradation products are difficult to isolate. The substantial amount of the short RNA accumulated in the HSA-N6-transfected COS cells and CHX-treated HSA-DelB transfectants may facilitate the study of the mechanism of RNA degradation.
An important aspect of the current study is the identification of a 43-bp fragment that can neutralize the negative cis element residing between nt 1289 and 1800. While multiple labile RNA contains negative cis elements (2, 24, 38, 45) , the existence of positive cis elements has been rarely reported (3, 9) . One such element has been reported for the transferrin receptor mRNA (4, 23, 31, 32) . However, no obvious homology can be found between these two positive cis-acting elements. It is therefore likely that the two elements may act by different mechanisms. Moreover, in the published studies (4, 23, 31, 32) the positive cis element is adjacent to the negative cis element, whereas in the HSA mRNA the positive and negative cis elements are about 1 kb apart in the linear sequence. The positive cis element described in this study does not have homology with other sequences implicated in RNA regulation. It is therefore likely that it prevents RNA degradation by a novel mechanism.
The coexistence of stabilizing and destabilizing cis-acting elements within the 3ЈUTR, as described in this study, has been rarely reported (18) . However, mRNA for the transferrin receptor possesses both of these two types of cis elements (4, 23, 31, 32) . Recent studies indicate that cellular factors that interact with these distinct elements can regulate the expression of transferrin receptor mRNA in response to variation in iron concentration (23, 32) . The presence of positive and negative cis elements within the 3ЈUTR of HSA mRNA suggests that the expression of HSA can be regulated by selectively activating or silencing the putative trans elements that act on the cis elements described in this paper. We show here that deletion within the 3ЈUTR of HSA selectively inactivates either positive or negative cis elements, which makes it possible to test the hypothesis by using a transgenic approach.
While the primary focus of the current study is to delineate the cis elements in the 3ЈUTR of the HSA mRNA that control its stability, several novel observations made in the study may have important implications for the mechanism of mammalian mRNA degradation, which has been difficult to study due to lack of degradation intermediates. Several species of HSADelB of approximate 1.0 kb are likely to be such intermediates. Thus, the full-length HSA-DelB transcript is detected in the nuclei but not in the cytoplasm. In contrast, the short pA Ϫ ORF-containing fragments were observed in the cytoplasm but not in the nuclei. Moreover, a large amount of HSA-DelB RNA, which contains the 3ЈUTR plus downstream vector sequence but not the ORF, is detected in the cytoplasm. These findings lead us to propose a model for degradation of HSADelB RNA (Fig. 11a) . First, the HSA transcript is cleaved at multiple sites to generate a spectrum of small fragments of approximately 1.0 kb. The 5Ј fragments, which contain the ORF but not poly(A), are subject to a rapid, CHX-sensitive degradation, while the 3Ј fragments, which contain the poly(A) tail, accumulate in a large amount. The relative speed and mechanism of the first endonucleic cleavage can be modulated by the ORF. For instance HSA-DelB cleavage is not prevented by CHX, while that for the B7-2-NE is CHX sensitive.
The HSA gene has two potential polyadenylation sites. Utilization of the first will produce a shorter mRNA devoid of the negative cis element. Thus, alternative polyadenylation will produce HSA mRNA subject to distinct posttranscriptional mechanisms (Fig. 11b) . Nevertheless, most cell types in animals utilize the second polyadenylation site, and the mRNAs are thus likely to be subject to the posttranscriptional mechanism defined in the current study.
The expression of HSA is under stringent developmental control. In the T-cell lineage, HSA is expressed among 50% of the CD4
Ϫ CD8 Ϫ and all CD4 ϩ CD8 ϩ thymocytes (15) . The level of HSA in T cells appears to correlate inversely with T-cell maturity (7). Hough et al. (13) have recently demonstrated that transgenic mice that constitutively express HSA at high levels have a very small thymus and a selective defect in generating either CD4 or CD8 T cells. These results indicate that down-regulation of HSA is a necessary step for T-cell maturation in the thymus. Clearly, understanding of the strict regulation of HSA expression will provide insights into the mechanism of lymphocyte development and activation.
